BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31448243)

  • 21. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
    Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
    Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
    Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
    Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy.
    Wang H; Li K; Ma L; Wu S; Hu J; Yan H; Jiang J; Li Y
    Virol J; 2017 Jan; 14(1):2. PubMed ID: 28081706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage Display-Derived Cross-Reactive Neutralizing Antibody against Enterovirus 71 and Coxsackievirus A16.
    Zhang X; Sun C; Xiao X; Pang L; Shen S; Zhang J; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    Jpn J Infect Dis; 2016; 69(1):66-74. PubMed ID: 26073737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway.
    Yang Q; Wu C; Zhu G; Ren F; Lin B; Huang R; Hu X; Zhao D; Peng K; Wu Y; Wang Q; Huang C; Zhang D
    Antiviral Res; 2023 Jan; 209():105498. PubMed ID: 36563943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils.
    Sun YS; Yang ZN; Xu F; Chen C; Lu HJ; Jiang JM; Zhang YJ; Zhu HP; Yao PP
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31906004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harmine, a small molecule derived from natural sources, inhibits enterovirus 71 replication by targeting NF-κB pathway.
    Chen D; Tian X; Zou X; Xu S; Wang H; Zheng N; Wu Z
    Int Immunopharmacol; 2018 Jul; 60():111-120. PubMed ID: 29730555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease.
    Yi EJ; Kim YI; Song JH; Ko HJ; Ahn SH; Lee HJ; Suh B; Yu J; Park J; Lee YJ; Jung EJ; Chang SY
    Vaccine; 2023 Sep; 41(41):6055-6063. PubMed ID: 37648607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.
    Liao CC; Liou AT; Chang YS; Wu SY; Chang CS; Lee CK; Kung JT; Tu PH; Yu YY; Lin CY; Lin JS; Shih C
    J Virol; 2014 Nov; 88(21):12485-99. PubMed ID: 25142603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.
    Lin CW; Liu CC; Lu TC; Liu SJ; Chow YH; Chong P; Huang MH
    Biomed Res Int; 2014; 2014():670506. PubMed ID: 25006583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice.
    Dai W; Bi J; Li F; Wang S; Huang X; Meng X; Sun B; Wang D; Kong W; Jiang C; Su W
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31284698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
    Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3C
    Xu B; Liu M; Ma S; Ma Y; Liu S; Shang L; Zhu C; Ye S; Wang Y
    Microbiol Spectr; 2021 Dec; 9(3):e0102521. PubMed ID: 34787443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
    Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
    Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.
    Yang J; Yang C; Guo N; Zhu K; Luo K; Zhang N; Zhao H; Cui Y; Chen L; Wang H; Gu J; Ge B; Qin CF; Leng Q
    J Virol; 2015 Nov; 89(21):10860-7. PubMed ID: 26292317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
    Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
    Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins.
    Gao M; Duan H; Liu J; Zhang H; Wang X; Zhu M; Guo J; Zhao Z; Meng L; Peng Y
    Antiviral Res; 2014 Jun; 106():80-5. PubMed ID: 24680956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of enterovirus 71 infection by polysaccharides extracted from Picochlorum sp. 122 via the AKT and ATM/ATR signaling pathways.
    Guo M; Zheng R; Wu HL; Chen D; Su J; Xu T; Wu H; Xiang W; Li Y; Zhu B
    Arch Virol; 2021 Dec; 166(12):3269-3274. PubMed ID: 34536128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication.
    Song J; Hu Y; Li J; Zheng H; Wang J; Guo L; Shi H; Liu L
    Arch Virol; 2018 Jan; 163(1):135-144. PubMed ID: 29052054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71.
    Yamayoshi S; Iizuka S; Yamashita T; Minagawa H; Mizuta K; Okamoto M; Nishimura H; Sanjoh K; Katsushima N; Itagaki T; Nagai Y; Fujii K; Koike S
    J Virol; 2012 May; 86(10):5686-96. PubMed ID: 22438546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.